Cyclosporine induces cancer progression by a cell-autonomous mechanism. - Wikidata - awgldk - TriplyDB

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

http://www.wikidata.org/entity/Q53426083

about

Posttransplantation malignancy in a patient presenting with weight loss and changed bowel habits: a case report Antamanide, a derivative of Amanita phalloides, is a novel inhibitor of the mitochondrial permeability transition pore The latent transforming growth factor beta binding protein (LTBP) family Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms Grape seed proanthocyanidines and skin cancer prevention: inhibition of oxidative stress and protection of immune system Is telomerase reactivation associated with the down-regulation of TGF beta receptor-II expression in human breast cancer?Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta Downregulation of calcineurin activity in cervical carcinoma Incidence, risk factors and outcomes of de novo malignancies post liver transplantation Solid, non-skin, post-liver transplant tumors: Key role of lifestyle and immunosuppression management Neoplastic disease after liver transplantation: Focus on de novo neoplasms Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis Melanoma Risk and Survival among Organ Transplant Recipients.Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion Characterization of a gene encoding two isoforms of a mitochondrial protein up-regulated by cyclosporin A in activated T cells Defective T cell development and function in calcineurin A beta -deficient mice Partial nephrectomy in a patient with a left ventricular assist device.Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance?Cancer incidence in kidney transplant recipients: a study protocol.A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma.Cyclosporine A improves adhesion and invasion of mouse preimplantation embryos via upregulating integrin β3 and matrix metalloproteinase-9 Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients.De novo papillary carcinoma in a renal allograft: the pros and cons of immunosuppression Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis.Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation.Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth.Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.Assessment of immunosuppressant drug carcinogenicity: standard and alternative animal models.Calcineurin inhibitor-induced and Ras-mediated overexpression of VEGF in renal cancer cells involves mTOR through the regulation of PRAS40 Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development Future prospects for anti-cytokine treatment.

P2860

Q21261410-01355A19-28AE-4C8D-BFE4-101410E4A0D8 Q21562115-D6649C77-7189-4373-94BA-FC27DE623177 Q24532213-49D42138-B15F-44AD-B014-46CFD3668D97 Q24534698-B72DDE73-7BF9-4E1D-A2BD-1A08656CBC54 Q24537383-28EAE3FC-B2A6-4ACE-9895-2996010D8F9C Q24655517-9E4DF121-148F-4763-A312-B49AECE9601C Q24656612-DFDD1E94-4A59-4A1F-B936-682CD067CB36 Q24791742-26E37BF9-ACFE-4566-AB0E-4F6930E331CA Q24793319-01778B41-E547-4A24-8AD5-FDDB79283862 Q24795040-528C3C18-516B-4D93-B7A8-833F2F91B269 Q26748580-07FCFA47-3456-47DE-95F2-36BEA02FBE14 Q26772295-5E08823C-D5A9-43E6-B705-FF3D2BB18132 Q26798306-75C1A69B-C151-493A-BAC5-4F4E5891C548 Q26830194-3D81FFAB-2AAC-4E6B-9AE8-6C52E37CC5B9 Q26851436-5561E3FD-B5F0-4355-94BE-1280961187BA Q27025406-2C8815B4-D88F-4E1E-800B-AA631D3498EB Q27320787-53E7180B-81D9-40AA-8870-03DF12B563A8 Q28067598-F9C2E1BE-3DB5-42B5-9CFC-9C7076176E7A Q28362221-66B5F10B-511A-4C10-8DD2-A60C1751D3AF Q28591382-93E01BE8-8D26-447A-8DF3-D3BFAD8AA405 Q28592115-528B8EE3-AB57-454E-A060-4DB9BB9CE709 Q30426882-5660A331-9028-4D8C-9F7A-4E5F37440CB9 Q33333473-DF13016B-7F15-484D-A020-3B1892B6DAC8 Q33346685-BE6EBC16-1131-4CCD-BC40-4C8E84FC6FEF Q33371289-72005122-2B61-42A3-A924-4ED5C07E95A7 Q33399015-930F29C1-9BDD-4278-9153-938154C5A501 Q33495757-39694461-46B4-4283-A83D-5AF68B963608 Q33575450-29DFC36B-0BCA-4877-B3C4-B2F309B75320 Q33582900-70723C83-3011-4575-98BD-F63766DA6B04 Q33614767-9EF88E2E-3B30-43EE-9635-110961D29E06 Q33622320-415484B4-9A76-4DC3-A323-3670FE23C834 Q33799731-572E0520-99BC-441E-BE39-841B4917A8F5 Q33880261-91E55630-EEFE-4170-B41D-769F3256FA1E Q33905617-ECE075F4-14D2-46AC-8AAB-F4F49E5EA452 Q33919087-D9C0C66C-CA0C-4802-AE41-5D18F07E60E9 Q33943659-DDFAEBC4-7DB4-4FE9-8323-A346B6AD7210 Q33986181-DE7D686F-B805-4719-8D81-02FD35057B00 Q34009025-5BE72531-74A4-4091-9CC8-62DBCC500119 Q34055699-3D5836A3-94E9-4ECB-B08F-37EE91F297D3 Q34071336-12540488-C3C9-4800-8C8C-1549C6F9C0FF

P2860

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

http://www.wikidata.org/entity/Q53426083

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

@en

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

@nl

type

label

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

@en

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

@nl

prefLabel

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

@en

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

@nl

P1433

Q53426083-1DF29EED-9A21-4BB3-808D-00C7C1CCFF81

P1476

Q53426083-4AB49F0A-27A0-47B7-AAE6-56C289410EF6

P2093

Q53426083-0324A94B-1EA7-4409-8EBD-816C484829F4

Q53426083-14D3CBD9-065E-4253-93BD-BF5088B59AC4

Q53426083-6607DF05-9738-4669-92B3-E7AF5F191709

Q53426083-79324CB3-C70C-45D9-85F6-3ADDBE431E9B

Q53426083-B310CA77-640A-46C6-B0D5-0BBA973867B4

Q53426083-CF737FC9-E4FD-4773-AEB5-346BB8A9D427

Q53426083-DDC465E1-A54D-44D3-AD3C-CC60417EBFC3

Q53426083-EAA27943-2C3F-40D4-A227-CAFF9A361A20

P2888

Q53426083-D21D2B36-6372-44AB-87C3-E3901D730687

P304

Q53426083-D43D200F-B2BF-4DD2-A767-5693B673AD9C

P31

Q53426083-2A044E4D-68A1-4335-A401-D49BA68A233F

P356

Q53426083-F219279B-B71C-4B5F-92DD-BC158267D7F2

P407

Q53426083-0BC3BE2D-9857-4FCE-9A7D-97FD74DE43A4

P433

Q53426083-B226DA21-E154-4125-8B74-44E06B82D816

P478

Q53426083-BA934EAC-427D-4DEE-B946-007359104F78

P577

Q53426083-C5A1CDBB-920D-4F22-87FC-0D78AE1E7BAE

P6179

Q53426083-4FEF3ED0-6E22-4AEA-9B46-47836E9FF37D

P698

Q53426083-5A46C0FF-D016-4A2A-ADD7-ABCB69D64E55

P356

P1433

P1476

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

@en

P2093

Asano T

http://www.w3.org/2001/XMLSchema#string

Hojo M

http://www.w3.org/2001/XMLSchema#string

Lagman M

http://www.w3.org/2001/XMLSchema#string

Maluccio M

http://www.w3.org/2001/XMLSchema#string

Morimoto K

http://www.w3.org/2001/XMLSchema#string

Morimoto T

http://www.w3.org/2001/XMLSchema#string

Shimbo T

http://www.w3.org/2001/XMLSchema#string

Suthanthiran M

http://www.w3.org/2001/XMLSchema#string

P2888

P304

530-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/17401

http://www.w3.org/2001/XMLSchema#string

P407

P433

6719

http://www.w3.org/2001/XMLSchema#string

P478

397

http://www.w3.org/2001/XMLSchema#string

P577

1999-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013680268

http://www.w3.org/2001/XMLSchema#string

P698

10028970

http://www.w3.org/2001/XMLSchema#string